Infection control 5KNIN216 & 6KNIN323
... submission. According to the method of submission as detailed on your KEATS site, if your work was submitted online you will be able to download marked coursework from KEATS; alternatively, if you completed a hard-copy submission you can collect your coursework and feedback from the Student Services ...
... submission. According to the method of submission as detailed on your KEATS site, if your work was submitted online you will be able to download marked coursework from KEATS; alternatively, if you completed a hard-copy submission you can collect your coursework and feedback from the Student Services ...
Limitations of Antibody Based Diagnostic Tests
... antibiotics for an infection that may not even exist. It makes more sense to consider other causes for their symptoms. Certainly, continual efforts should be made to improve existing technology so that diagnostic tests are able to detect small amounts of antibody early during the course of an infect ...
... antibiotics for an infection that may not even exist. It makes more sense to consider other causes for their symptoms. Certainly, continual efforts should be made to improve existing technology so that diagnostic tests are able to detect small amounts of antibody early during the course of an infect ...
Infection Prevention Core Practices
... appropriate and specific for their work assignments, so that personnel can maintain accurate and up-to date knowledge about the essential elements of infection control(IB/IC) • Isolation Guideline: Provide job-specific training to staff and update periodically(II) • MDRO Guideline: Provide educa ...
... appropriate and specific for their work assignments, so that personnel can maintain accurate and up-to date knowledge about the essential elements of infection control(IB/IC) • Isolation Guideline: Provide job-specific training to staff and update periodically(II) • MDRO Guideline: Provide educa ...
An Update on Emerging Infectious Diseases
... infections • Minorities affected disproportionately [as is the case with many other infectious diseases] – 54% active M. Tuberculosis cases (1995) reported among African American and Hispanic populations – An additional 17.5% among Asians • In some U.S. sectors, morbidity rates surpass those of poor ...
... infections • Minorities affected disproportionately [as is the case with many other infectious diseases] – 54% active M. Tuberculosis cases (1995) reported among African American and Hispanic populations – An additional 17.5% among Asians • In some U.S. sectors, morbidity rates surpass those of poor ...
Pneumonia-What is the infection?
... community acquired infections (e.g. ertapenem). Group 2 includes broad-spectrum Carbapenems, with activity against nonfermentative Gram-negative bacilli that are particularly suitable for nosocomial infections (e.g. imipenem and meropenem) ...
... community acquired infections (e.g. ertapenem). Group 2 includes broad-spectrum Carbapenems, with activity against nonfermentative Gram-negative bacilli that are particularly suitable for nosocomial infections (e.g. imipenem and meropenem) ...
Adenovirus and Adenoviral Vectors
... viral DNA is transported to the nucleus, resulting in transient expression of viral genes since adenoviral DNA is not integrated in the host genome (it remains in an episomal state). The life cycle of adenovirus is separated by the DNA replication process in two distinct phases: the early and late p ...
... viral DNA is transported to the nucleus, resulting in transient expression of viral genes since adenoviral DNA is not integrated in the host genome (it remains in an episomal state). The life cycle of adenovirus is separated by the DNA replication process in two distinct phases: the early and late p ...
immunological responses after a booster dose of hbv vaccine in hiv
... viral load was undetectable in all of them, median CD4+ count 718 mm3. All patients received a booster dose of HBV vaccine (HBVAXPRO 10 micrograms i.m.). HBV-specific Ab titer, viral load and CD4 + were measured in all subjects at baseline (T0), at 1 (T1), 6 (T6) and 12 (T12) months after the booste ...
... viral load was undetectable in all of them, median CD4+ count 718 mm3. All patients received a booster dose of HBV vaccine (HBVAXPRO 10 micrograms i.m.). HBV-specific Ab titer, viral load and CD4 + were measured in all subjects at baseline (T0), at 1 (T1), 6 (T6) and 12 (T12) months after the booste ...
Zoonosis
... not until late in the course of the illness. • Only vegetative encapsulated bacilli are present during infection, spores are not found in the blood. ...
... not until late in the course of the illness. • Only vegetative encapsulated bacilli are present during infection, spores are not found in the blood. ...
AR-0113-03 Swine Vesicular Disease Virus _SVDV_ RT
... Swine vesicular disease (SVD) is an acute, contagious viral disease of swine caused by the swine vesicular disease virus, (belonging to family Picornaviridae, genus Enterovirus). It is characterized by fever and vesicles with subsequent ulcers in the mouth and on the snout, feet, and teats, but does ...
... Swine vesicular disease (SVD) is an acute, contagious viral disease of swine caused by the swine vesicular disease virus, (belonging to family Picornaviridae, genus Enterovirus). It is characterized by fever and vesicles with subsequent ulcers in the mouth and on the snout, feet, and teats, but does ...
Facts about HIV and AIDS
... Globally HIV and AIDS is a much greater problem than in Iceland. During the past twenty years over 60 million people have been infected with HIV throughout the world. It was estimated by the beginning of the year 2003 that 42 million men, women and children now alive are infected with HIV or AIDS, a ...
... Globally HIV and AIDS is a much greater problem than in Iceland. During the past twenty years over 60 million people have been infected with HIV throughout the world. It was estimated by the beginning of the year 2003 that 42 million men, women and children now alive are infected with HIV or AIDS, a ...
View/Open - Repository | UNHAS
... Tuberculosis (TB) remains a major global health problem. Human TB is the most frequent cause of seath from a single infectious agent, being responsible for about two million people die every year worldwide [1]. About 90% of people who get infected with TB develop a latent TB infection. People who ha ...
... Tuberculosis (TB) remains a major global health problem. Human TB is the most frequent cause of seath from a single infectious agent, being responsible for about two million people die every year worldwide [1]. About 90% of people who get infected with TB develop a latent TB infection. People who ha ...
Annual Bloodborne Pathogen Training
... HIV/AIDS Hepatitis B (HBV) Hepatitis C (HCV) Hepatitis D (HDV) ...
... HIV/AIDS Hepatitis B (HBV) Hepatitis C (HCV) Hepatitis D (HDV) ...
INTENDED USE SUMMARY PRINCIPLE OF THE TEST Principle of
... biologic properties.10 In recent times, the subdivision of HSV into specific types has become possible. The occurrence of HSV-2 antibodies can vary from 3 percent to 70 percent depending on the population.11 The major period of infection with HSV-2 is during the ages of 14-29 and HSV-2 infection is ...
... biologic properties.10 In recent times, the subdivision of HSV into specific types has become possible. The occurrence of HSV-2 antibodies can vary from 3 percent to 70 percent depending on the population.11 The major period of infection with HSV-2 is during the ages of 14-29 and HSV-2 infection is ...
Micro Chapter 23 [4-20
... droplets are destroyed before they can multiply Nearly all TB in previously infected people is from endogenous reactivation o However when the airborne inoculum is large, or when host defenses are compromised, exogenous reinfection can happen Age influences the course of the TB infection o Kids unde ...
... droplets are destroyed before they can multiply Nearly all TB in previously infected people is from endogenous reactivation o However when the airborne inoculum is large, or when host defenses are compromised, exogenous reinfection can happen Age influences the course of the TB infection o Kids unde ...
Ebola Virus Outbreak
... with blood or another body fluid, such as feces or vomit, from an infected person, or with an object that is contaminated with infected body fluids. • Following contact, the virus must enter an opening in the body, like a break in the skin or the eyes, nose, or mouth. • Ebola virus does not spread t ...
... with blood or another body fluid, such as feces or vomit, from an infected person, or with an object that is contaminated with infected body fluids. • Following contact, the virus must enter an opening in the body, like a break in the skin or the eyes, nose, or mouth. • Ebola virus does not spread t ...
bloodborne pathogens in heavy industry
... Hepatitis is a liver disease. It usually results in an inflammation of the liver, and frequently progresses to more serious conditions such as: — Cirrhosis. — Cancer. Each year in the U.S. there are over 70,000 new cases of Hepatitis B, and it is estimated that more than 3 million people are car ...
... Hepatitis is a liver disease. It usually results in an inflammation of the liver, and frequently progresses to more serious conditions such as: — Cirrhosis. — Cancer. Each year in the U.S. there are over 70,000 new cases of Hepatitis B, and it is estimated that more than 3 million people are car ...
TB Medications and the Liver
... drugs if: ALT > 5 x ULN ALT > 3 x ULN + jaundice or symptoms Check Hepatits virus serology/ other drugs / alcohol If indicated, until cause determined, treat with 3 drugs less likely to cause ...
... drugs if: ALT > 5 x ULN ALT > 3 x ULN + jaundice or symptoms Check Hepatits virus serology/ other drugs / alcohol If indicated, until cause determined, treat with 3 drugs less likely to cause ...
HBV Training Workshop
... • HBV Advocate: www.HBVAdvocate.org • CDC – Viral Hepatitis: www.cdc.gov/hepatitis/ • Hepatitis B Foundation: www.hbf.org ...
... • HBV Advocate: www.HBVAdvocate.org • CDC – Viral Hepatitis: www.cdc.gov/hepatitis/ • Hepatitis B Foundation: www.hbf.org ...
Concept Analysis Diagram
... Immunity is a physiologic process that provides an individual with protection or defense from disease. Exemplars Vaccines Otitis media Urinary Tract Infection Cellulitis Osteomyelitis Pneumonia Appendicitis Trauma-sprain Objectives 1. Explain the correlation between the listed exemplars and the conc ...
... Immunity is a physiologic process that provides an individual with protection or defense from disease. Exemplars Vaccines Otitis media Urinary Tract Infection Cellulitis Osteomyelitis Pneumonia Appendicitis Trauma-sprain Objectives 1. Explain the correlation between the listed exemplars and the conc ...
Snímek 1
... • Early clinical manifestation (weeks-months) • Severe and complicated infections affecting respiratory and gastrointestinal tract and the skin • Failure to thrive • Frequent diarrhea • Usually lymphocytopenia • T-cell deficiency, B cell present in some patients • Decreased immunoglobulin levels ...
... • Early clinical manifestation (weeks-months) • Severe and complicated infections affecting respiratory and gastrointestinal tract and the skin • Failure to thrive • Frequent diarrhea • Usually lymphocytopenia • T-cell deficiency, B cell present in some patients • Decreased immunoglobulin levels ...
Hepatitis B
Hepatitis B is an infectious disease caused by the hepatitis B virus (HBV) which affects the liver. It can cause both acute and chronic infections. Many people have no symptoms during the initial infection. Some develop a rapid onset of sickness with vomiting, yellowish skin, feeling tired, dark urine and abdominal pain. Often these symptoms last a few weeks and rarely does the initial infection result in death. It may take 30 to 180 days for symptoms to begin. In those who get infected around the time of birth 90% develop chronic hepatitis B while less than 10% of those infected after the age of five do. Most of those with chronic disease have no symptoms; however, cirrhosis and liver cancer may eventually develop. These complications results in the death of 15 to 25% of those with chronic disease.The virus is transmitted by exposure to infectious blood or body fluids. Infection around the time of birth or from contact with other people's blood during childhood is the most frequent method by which hepatitis B is acquired in areas where the disease is common. In areas where the disease is rare, intravenous drug use and sexual intercourse are the most frequent routes of infection. Other risk factors include working in healthcare, blood transfusions, dialysis, living with an infected person, travel in countries where the infection rate is high, and living in an institution. Tattooing and acupuncture led to a significant number of cases in the 1980s; however, this has become less common with improved sterility. The hepatitis B viruses cannot be spread by holding hands, sharing eating utensils, kissing, hugging, coughing, sneezing, or breastfeeding. The infection can be diagnosed 30 to 60 days after exposure. Diagnosis is typically by testing the blood for parts of the virus and for antibodies against the virus. It is one of five known hepatitis viruses: A, B, C, D, and E.The infection has been preventable by vaccination since 1982. Vaccination is recommended by the World Health Organization in the first day of life if possible. Two or three more doses are required at a later time for full effect. This vaccine works about 95% of the time. About 180 countries gave the vaccine as part of national programs as of 2006. It is also recommended that all blood be tested for hepatitis B before transfusion and condoms be used to prevent infection. During an initial infection, care is based on the symptoms that a person has. In those who develop chronic disease antiviral medication such as tenofovir or interferon maybe useful, however these drugs are expensive. Liver transplantation is sometimes used for cirrhosis.About a third of the world population has been infected at one point in their lives, including 240 million to 350 million who have chronic infections. Over 750,000 people die of hepatitis B each year. About 300,000 of these are due to liver cancer. The disease is now only common in East Asia and sub-Saharan Africa where between 5 and 10% of adults have chronic disease. Rates in Europe and North America are less than 1%. It was originally known as serum hepatitis. Research is looking to create foods that contain HBV vaccine. The disease may affect other great apes as well.